ADVANCED WOUND CARE PRODUCTS MARKET

159 Pages | 31 Exhibits | 2016 Analysis | Forecasts Through 2020

OVERVIEW:
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global tissue-engineered skin replacements/substitutes, active wound repair modulators, advanced wound closure products, and advanced wound dressings markets.

ADVANCED WOUND CARE MARKET HIGHLIGHTS

  • Product innovation and robust growth have intensified in the US advanced wound care products market in recent years; however, similar growth patterns have yet to be realized in other geographic regions. The US accounts for more than 50% of the advanced wound care products market as a whole, but accounts for more than 70% of NPWT, and more than 90% of tissue-engineered skin replacements/substitutes.
  • The combined global market for advanced wound care products totaled more than $7bn in 2015, and is expected to climb at a CAGR of 5.2% over the forecast period, reaching more than $10bn in 2020.
  • Advanced wound dressings are experiencing particularly dynamic growth, driven by increased use of foam dressings. This market is expected to increase from $2.5bn in 2015 to nearly $4bn in 2020, a CAGR of 9%.
  • In the biologics segment, amniotic tissue grafts are a fast-growing technology, with positive clinical outcomes and the rapid introduction of new technology driving market growth.
Key Questions Answered
  • What are the key drivers and limiters to the global advanced wound care products market?
  • How are reimbursement/regulatory issues and price competition affecting product development and market growth?
  • How are technological advancements impacting market trends?
  • Which areas of the advanced wound care products market are experiencing dynamic growth in the US and internationally?


TABLE OF CONTENTS:
EXECUTIVE SUMMARY

i. Tissue-engineered skin replacement and substitutes 
ii. Active wound repair modulators 
iii. Advanced wound closure products
iv. Advanced wound dressings
v. Market analysis 
vi. Methodology

Exhibit ES-1: Advanced wound care products, market forecast, 2015-20

1. TISSUE-ENGINEERED SKIN REPLACEMENTS AND SUBSTITUTES

1.1 Allografts 
1.2 Autografts 
1.3 Xenografts 
1.4 Autologous and tissue-engineered skin replacements/substitutes 
	1.4.1 Epidermal equivalent products 
	1.4.2 Dermal equivalent products
	1.4.3 Multilayer equivalent products 
	1.4.4 Amniotic tissue grafts 
1.5 Market forecast
1.6 Competitive analysis
1.7 Bibliography

Exhibit 1-1: Tissue-engineered skin replacements and substitutes, market forecast, 2015-20
Exhibit 1-2: Tissue-engineered skin replacements and substitutes market, share by supplier, 2015 

2. ACTIVE WOUND REPAIR MODULATORS

2.1 Growth factors 
	2.1.1 Growth factor classification
		2.1.1.1 Fibroblast growth factor
		2.1.1.2 Transforming growth factor 
		2.1.1.3 Epidermal growth factor 
		2.1.1.4 Platelet-derived growth factor
		2.1.1.5 Insulin-like growth factor
		2.1.1.6 Keratinocyte growth factor
		2.1.1.7 Vascular endothelial growth factor 
		2.1.1.8 Autologous growth factor
		2.1.1.9 Summary of angiogenic growth factors 
	2.1.2 Competitors and products 
	2.1.3 Market forecast
2.2 Gene therapy agents
2.3 Stem cells
	2.3.1 Types of stem cells
		2.3.1.1 Embryonic stem cells 
		2.3.1.2 Adult stem cells 
		2.3.1.3 Cord blood stem cells
	2.3.2 The role of stem cells in wound healing
	2.3.3 Market status
2.4 Other active wound repair modulators and pharmaceuticals
	2.4.1 Antibiotics and anti-infectives 
	2.4.2 Hormones
	2.4.3 Matrix metalloproteinase enzyme inhibitors
	2.4.4 Neuropeptides in diabetic wounds
	2.4.5 Other products
2.5 Bibliography

Exhibit 2-1: Selected growth factors in development for wound healing applications 
Exhibit 2-2: The angiogenesis process
Exhibit 2-3: Selected angiogenic growth factors, 2016
Exhibit 2-4: Growth factors, market forecast, 2015-20 

3. ADVANCED WOUND CLOSURE PRODUCTS MARKET
 
3.1 Surgical sealants and glues
	3.1.1 Applications
	3.1.2 Fibrin sealants 
		3.1.2.1 Composition 
		3.1.2.2 Application methods 
	3.1.3 Autologous-processed sealants 
	3.1.4 Collagen- and albumin-based sealants 
	3.1.5 Cyanoacrylate-based sealants 
	3.1.6 Polymer-based sealants
	3.1.7 Market analysis 
	3.1.8 Competitive analysis 
3.2 Energy-based wound closure products 
	3.2.1 Radiofrequency closure
		3.2.1.1 Monopolar/bipolar
	3.2.2 Ultrasonic closure
	3.2.3 Thermal closure
	3.2.4 Market analysis 
	3.2.5 Competitive analysis 
3.3 Automated suturing devices 
	3.3.1 Market analysis 
	3.3.2 Competitive analysis 
3.4 Negative pressure wound therapy
	3.4.1 Market analysis 
	3.4.2 Competitive analysis 
3.5 Combined market analysis 
3.6 Bibliography

Exhibit 3-1: Surgical sealants and glues, market forecast, 2015-20
Exhibit 3-2: Surgical sealants and glues market, share by supplier, 2015
Exhibit 3-3: Energy-based wound closure devices, market forecast, 2015-20 
Exhibit 3-4: Energy-based wound closure devices market, share by supplier, 2015 
Exhibit 3-5: Automated suturing products, market forecast, 2015-20
Exhibit 3-6: Automated suturing products market, share by supplier, 2015
Exhibit 3-7: Negative pressure wound therapy products, market forecast, 2015-20
Exhibit 3-8: Negative pressure wound therapy products market, share by supplier, 2015 
Exhibit 3-9: Advanced wound closure products, combined market forecast, 2015-20

4. ADVANCED WOUND DRESSINGS

4.1 Alginate dressings 
	4.1.1 Market forecast
	4.1.2 Competitive analysis 
4.2 Film dressings 
	4.2.1 Market forecast
	4.2.2 Competitive analysis 
4.3 Foam dressings
	4.3.1 Market forecast
	4.3.2 Competitive analysis 
4.4 Hydrocolloid dressings 
	4.4.1 Market forecast
	4.4.2 Competitive analysis 
4.5 Hydrogel wound care products
	4.5.1 Market forecast
	4.5.2 Competitive analysis 
4.6 Wound contact layer dressings 
	4.6.1 Market forecast
	4.6.2 Competitive analysis 
4.7 Antimicrobial dressings
	4.7.1 Market forecast
	4.7.2 Competitive analysis 
4.8 Combined market analysis 
4.9 Bibliography

Exhibit 4-1: Alginate wound dressings, market forecast, 2015-20
Exhibit 4-2: Alginate wound dressings market, share by supplier, 2015
Exhibit 4-3: Film wound dressings, market forecast, 2015-20 
Exhibit 4-4: Film wound dressings market, share by supplier, 2015
Exhibit 4-5: Foam wound dressings, market forecast, 2015-20
Exhibit 4-6: Foam wound dressings market, share by supplier, 2015 
Exhibit 4-7: Hydrocolloid wound dressings, market forecast, 2015-20 
Exhibit 4-8: Hydrocolloid wound dressings market, share by supplier, 2015
Exhibit 4-9: Hydrogel wound care products, market forecast, 2015-20 
Exhibit 4-10: Hydrogel wound care products market, share by supplier, 2015
Exhibit 4-11: Wound contact layer dressings, market forecast, 2015-20
Exhibit 4-12: Wound contact layer dressings market, share by supplier, 2015 
Exhibit 4-13: Silver-containing antimicrobial wound dressings, market forecast, 2015-20
Exhibit 4-14: Silver-containing antimicrobial wound dressings market, share by supplier, 2015 
Exhibit 4-15: Advanced wound dressings, combined market forecast, 2015-20 

APPENDIX A: COMPANY LISTING 


COMPANIES COVERED:

  1. 3M Health Care/3M
  2. Acelity
  3. AediCell
  4. Advanced Medical Solutions
  5. Afassco
  6. Alliqua BioMedical
  7. Amarantus BioScience Holdings
  8. Amniox Medical/TissueTech
  9. Argentum Medical
  10. ArthroCare/Smith & Nephew
  11. Avita Medical
  12. Baxter Healthcare/Baxter International
  13. Bio Med Sciences
  14. Cardinal Health
  15. Cohera Medical
  16. Coloplast
  17. ConvaTec/Nordic Capital and Avista Capital Partners
  18. Covalon Technologies
  19. CR Bard
  20. CryoLife
  21. CSL Behring/CSL Limited
  22. DermaRite Industries
  23. Derma Sciences
  24. DeRoyal Industries
  25. EndoEvolution
  26. EndoGastric Solutions
  27. Ethicon/Johnson & Johnson
  28. Ferris Manufacturing
  29. GEM
  30. Genentech/F. Hoffmann-La Roche
  31. Gentell
  32. Genzyme/Sanofi
  33. Halyard Health
  34. Harvest Technologies/Terumo
  35. Healthpoint Biotherapeutics/Smith & Nephew
  36. Hollister
  37. Integra LifeSciences
  38. Isto Biologics/Isto Holdings
  39. Kaken Pharmaceutical
  40. LSI Solutions
  41. Medi-Tech International
  42. Medline Industries
  43. Medtronic
  44. Medtronic Minimally Invasive Therapies/Medtronic
  45. Merck
  46. Metasurg/Integra Lifesciences
  47. Microline Surgical/HOYA
  48. MiMedx Group
  49. Molnlycke Health Care
  50. MPM Medical/RBC Life Sciences
  51. Musculoskeletal Transplant Foundation
  52. Mylan
  53. Noble Biomaterials
  54. Novartis
  55. Nuo Therapeutics
  56. NuTech
  57. Olympus America/Olympus
  58. Organogenesis
  59. Osiris Therapeutics
  60. PARE Surgical
  61. Promethean LifeSciences
  62. RegeneRx
  63. Regenerys
  64. Regenicin
  65. Sanofi
  66. Smith & Nephew
  67. Southwest Technologies
  68. Stratatech
  69. TEI Biosciences/Integra LifeSciences
  70. Theravance Biopharma
  71. TissueSeal
  72. Tornier
  73. USGI Medical
  74. Vericel
  75. Winfield Laboratories
  76. Wright Medical Technology/Wright Medical Group
  77. Zimmer Biomet
Contact Us

Need help finding medtech research? Let us help you!